PPARα protects proximal tubular cells from acute fatty acid toxicity

Journal of the American Society of Nephrology

Volumn 18, Issue 12, 2007, Pages 3089-3100

  Kamijo, Yuji ^a   Hora, Kazuhiko ^a   Kono, Keiichi ^a   Takahashi, Kyoko ^a   Higuchi, Makoto ^a   Ehara, Takashi ^a   Kiyosawa, Kendo ^a   Shigematsu, Hidekazu ^a   Gonzalez, Frank J ^b   Aoyama, Toshifumi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; FATTY ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN; MESSENGER RNA;

ACUTE TOXICITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FATTY ACID METABOLISM; FEMALE; HOMEOSTASIS; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; KIDNEY TUBULE DAMAGE; MODULATION; MOUSE; NEPHROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEINURIA; WILD TYPE; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; KIDNEY; KIDNEY TUBULE; METABOLISM; MOUSE MUTANT; NICK END LABELING; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; FATTY ACIDS; IN SITU NICK-END LABELING; KIDNEY; KIDNEY DISEASES; KIDNEY TUBULES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PPAR ALPHA; PROTEINS; PROTEINURIA; RNA, MESSENGER;

EID: 36848998955     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2007020238     Document Type: Article

References (47)

1. D'Amico G: Tubulointerstitum as predictor of progression of glomerular diseases. Nephron 83: 289-295, 1999
2. Remuzzi G, Bertani T: Pathophysiology of progressive nephropathies. N Engl J Med 339: 1448-1456, 1998
3. Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hase H, Kaneko T, Hirata Y, Goto A, Fujita T, Omata M: Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage. Kidney Int 62: 1628-1637, 2002
4. Thomas ME, Harris KP, Walls J, Furness PN, Brunskill NJ: Fatty acids exacerbate tubulointerstitial injury in protein-overload proteinuria. Am J Physiol Renal Physiol 283: F640-F647, 2002
5. Tang S, Leung JC, Abe K, Chan KW, Chan LY, Chan TM, Lai KN: Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo. J Clin Invest 111: 515-527, 2003
6. Chen L, Boadle RA, Harris DC: Toxicity of holotransferrin but not albumin in proximal tubule cells in primary culture. J Am Soc Nephrol 9: 77-84, 1998
7. Nangaku M, Pippin J, Couser WG: Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome. J Am Soc Nephrol 10: 2323-2331, 1999
8. Ong AC, Moorhead JF: Tubular lipidosis: Epiphenomenon or pathogenetic lesion in human renal disease? Kidney Int 45: 753-762, 1994
9. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH: Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: Impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci U S A 91: 10878-10882, 1994
10. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH: Lipotoxic heart disease in obese rats: Implications for human obesity. Proc Natl Acad Sci U S A 97: 1784-1789, 2000
11. Shimabukuro M, Zhou YT, Levi M, Unger RH: Fatty acid-induced beta cell apoptosis: A link between obesity and diabetes. Proc Natl Acad Sci U S A 95: 2498-2502, 1998
12. Listenberger LL, Ory DS, Schaffer JE: Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J Biol Chem 276: 14890-14895, 2001
13. Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, Gonzalez FJ: Altered constitutive expression of fatty acid-metabolising enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem 273: 5678-5684, 1998
14. Watanabe K, Fujii H, Takahashi T, Kodama M, Aizawa Y, Ohta Y, Ono T, Hasegawa G, Naito M, Nakajima T, Kamijo Y, Gonzalez FJ, Aoyama T: Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity. J Biol Chem 275: 22293-22299, 2000
15. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W: Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, -gamma in the adult rat. Endocrinology 137: 354-366, 1996
16. Guerre-Millo M, Gervois P, Raspe E, Madsen L, Poulain P, Derudas B, Herbert JM, Winegar DA, Willson TM, Fruchart JC, Berge RK, Staels B: Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J Biol Chem 275: 16638-16642, 2000
17. Peters JM, Aoyama T, Cattley RC, Usuda N, Hashimoto T, Gonzalez FJ: Role of peroxisome proliferator-activated receptor α in altered cell cycle regulation in mouse liver. Carcinogenesis 19: 1989-1994, 1998
18. Delerive P, Fruchart JC, Staels B: Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol 169: 453-459, 2001
19. Kamijo Y, Hora K, Tanaka N, Usuda N, Kiyosawa K, Nakajima T, Gonzalez FJ, Aoyama T: Identification of functions of peroxisome proliferator-activated receptor alpha in proximal tubules. J Am Soc Nephrol 13: 1691-1702, 2002
20. Suzuki Y, Lopez-Franco O, Gomez-Garre D, Tejera N, Gomez-Guerrero C, Sugaya T, Bemal R, Blanco J, Ortega L, Egido J: Renal tubulointerstitial damage caused by persistent proteinuria is attenuated in AT1-deficient mice: role of endothelin-1. Am J Pathol 159: 1895-1904, 2001
21. Carlsson C, Borg LA, Welsh N: Sodium palmitate induces partial mitochondrial uncoupling and reactive oxygen species in rat pancreatic islets in vitro. Endocrinology 140: 3422-3428, 1999
22. Kharroubi I, Ladriere L, Cardozo AK, Dogusan Z, Cnop M, Eizirik DL: Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: Role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology 145: 5087-5096, 2004
23. Delerive P, De Bosscher K, Vanden Berghe W, Fruchart JC, Haegeman G, Staels B: DNA binding-independent induction of IkappaBalpha gene transcription by PPARalpha. Mol Endocrinol 16: 1029-1039, 2002
24. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W: Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 103: 1489-1498, 1999
25. Schrauwen P, Hesselink MK: Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 53: 1412-1417, 2004
26. Glatz JF, Vork MM, van der Vusse GJ: Significance of cytoplasmic fatty acid-binding protein for the ischemic heart. Mol Cell Biochem 123: 167-173, 1993
27. Coe NR, Bernlohr DA: Physiological properties and functions of intra-cellular fatty acid-binding proteins. Biochim Biophys Acta 1391: 287-306, 1998
28. Listenberger LL, Han X, Lewis SE, Cases S, Farese RV Jr, Ory DS, Schaffer JE: Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci U S A 100: 3077-3082, 2003
29. Kamijo A, Sugaya T, Hikawa A, Okada M, Okumura F, Yamanouchi M, Honda A, Okabe M, Fujino T, Hirata Y, Omata M, Kaneko R, Fujii H, Fukamizu A, Kimura K: Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules. Am J Pathol 165: 1243-1255, 2004
30. Girnun GD, Domann FE, Moore SA, Robbins ME: Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Mol Endocrinol 16: 2793-2801, 2002
31. Yoo HY, Chang MS, Rho HM: Induction of the rat Cu/Zn superoxide dismutase gene through the peroxisome proliferator-responsive element by arachidonic acid. Gene 234: 87-91, 1999
32. Nakajima T, Kamijo Y, Tanaka N, Sugiyama E, Tanaka E, Kiyosawa K, Fukushima Y, Peters JM, Gonzalez FJ, Aoyama T: Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage. Hepatology 40: 972-980, 2004
33. Kamijo Y, Hora K, Nakajima T, Kono K, Takahashi K, Ito Y, Higuchi M, Kiyosawa K, Shigematsu H, Gonzalez FJ, Aoyama T: Peroxisome proliferator- activated receptor alpha protects against glomerulonephritis induced by long-term exposure to the plasticizer di-(2-ethylhexy- l)phthalate. J Am Soc Nephrol 18: 176-188, 2007
34. Shimabukuro M, Wang MY, Zhou YT, Newgard CB, Unger RH: Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression. Proc Natl Acad Sci U S A 95: 9558-9561, 1998
35. Green DR, Reed JC: Mitochondria and apoptosis. Sience 281: 1309-1312, 1998
36. Roberts RA, James NH, Woodyatt NJ, Macdonald N, Tugwood JD: Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha). Carcinogenesis 19: 43-48, 1998
37. Arid M, Chana R, Lewington A, Brown J, Brunskill NJ: Stimulation of proximal tubular cell apoptosis by albumin-bound fatty acids mediated by peroxisome proliferator activated receptor-gamma. J Am Soc Nephrol 14: 17-27, 2003
38. Schreck R, Albermann K, Baeuerle PA: Nuclear factor kappa B: An oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radie Res Commun 17: 221-237, 1992
39. Morigi M, Macconi D, Zoja C, Donadelli R, Buelli S, Zanchi C, Ghilardi M, Remuzzi G: Protein overload-induced NF-kappaB activation in proximal tubular cells requires H202 through a PKC-dependent pathway. J Am Soc Nephrol 13: 1179-1189, 2002
40. Li S, Gokden N, Okusa MD, Bhatt R, Portilla D: Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF. Am J Physiol Renal Physiol 289: F469-F480, 2005
41. Lee SS, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Femandez-Salguero PM, Westphal H, Gonzalez FJ: Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15: 3012-3022, 1995
42. Shindo Y, Hashimoto T: Acyl-Coenzyme A synthetase and fatty acid oxidation in rat liver peroxisomes. J Biochem 84: 1177-1181, 1978
43. Izai K, Uchida Y, Orii T, Yamamoto S, Hashimoto T: Novel fatty acid beta-oxidation enzymes in rat liver mitochondria. I. Purification and properties of very-long-chain acyl-coenzyme A dehydrogenase. J Biol Chem 267: 1027-1033, 1992
44. Uchida Y, Izai K, Orii T, Hashimoto T: Novel fatty acid beta-oxidation enzymes in rat liver mitochondria. II. Purification and properties of enoyl-coenzyme A (CoA) hydratase/3-hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase trifunctional protein. J Biol Chem 267: 1034-1041, 1992
45. Miyazawa S, Osumi T, Hashimoto T: The presence of a new 3-oxoacyl-CoA thiolase in rat liver peroxisomes. Eur J Biochem 103: 589-596, 1980
46. Osumi T, Hashimoto T: Purification and properties of mitochondrial and peroxisomal 3-hydroxyacyl-CoA dehydrogenase from rat liver. Arch Biochem Biophys 203: 372-383, 1980
47. Furuta S, Hayashi H, Hijikata M, Miyazawa S, Osumi T, Hashimoto T: Complete nucleotide sequence of cDNA and deduced amino acid sequence of rat liver catalase. Proc Natl Acad Sci U S A 83: 313-317, 1986